IDEXX Laboratories

IDXX64

S&P500

$506.73arrow_drop_down1.99%-$10.32

S&P500

IDXX64

$506.73

arrow_drop_down1.99%-$10.32

S&P500

Performance History

Key Stats
Open	$515.32
Prev. Close	$517.06
EPS	10.09
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	504.47	515.32
52 Week Range	372.50	583.39

Ratios







EPS	10.09

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About IDEXX Laboratories (IDXX)

IDEXX Laboratories Inc. (IDXX) is a leading provider of veterinary diagnostic tests, software, and services for the companion animal veterinary, livestock and poultry, and dairy markets worldwide. The company's products and services are used by veterinarians to diagnose, treat, and manage diseases in animals, and to support the overall health and wellness of pets and livestock. With a market cap of over $40 billion, IDEXX is one of the largest companies in the animal health industry.

IDEXX offers a wide range of diagnostic tests for pets, including blood chemistry, urinalysis, hematology, and infectious disease testing. The company's innovative IDEXX VetLab in-clinic analyzers provide fast and accurate results, enabling veterinarians to make more informed treatment decisions. In addition, IDEXX offers a suite of cloud-based software solutions that help veterinarians manage their practices more efficiently, improve patient care, and enhance client communication.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Mr. Jonathan J. Mazelsky
Headquarters: Westbrook
Employees: 10780
Exchange: NASDAQ

Keep an eye on IDEXX Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is IDEXX Laboratories 's (IDXX) price per share?

The current price per share for IDEXX Laboratories (IDXX) is $506.74. The stock has seen a price change of -$10.32 recently, indicating a -2% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for IDEXX Laboratories (IDXX)?

For IDEXX Laboratories (IDXX), the 52-week high is $583.39, which is 15.13% from the current price. The 52-week low is $372.5, the current price is 36.04% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is IDEXX Laboratories (IDXX) a growth stock?

IDEXX Laboratories (IDXX) has shown an average price growth of 0.41% over the past three years. It has received a score of 48 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying IDEXX Laboratories as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is IDEXX Laboratories (IDXX) stock price performance year to date (YTD)?

As of the latest data, IDEXX Laboratories (IDXX) has a year-to-date price change of -7.48%. Over the past month, the stock has experienced a price change of 2.37%. Over the last three months, the change has been 2.22%. Over the past six months, the figure is -4.76%. Looking at a longer horizon, the five-year price change stands at 83.74%.

help

Is IDEXX Laboratories (IDXX) a profitable company?

IDEXX Laboratories (IDXX) has a net income of $845.04M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 59.82% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 32.41% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $3.66B, with a revenue growth rate of 8.72%, providing insight into the company's sales performance and growth. The gross profit is $2.19B. Operating income is noted at $1.1B. Furthermore, the EBITDA is $1.22B.

help

What is the market capitalization of IDEXX Laboratories (IDXX)?

IDEXX Laboratories (IDXX) has a market capitalization of $41.71B. The average daily trading volume is 398.61K, indicating the stock's liquidity and investor engagement.